已收盤 04-02 16:00:00 美东时间
-0.110
-5.14%
Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that
03-31 20:14
Enveric Biosciences press release (ENVB): Q4 GAAP EPS of -$6.12. The company had cash-on-hand of $4.7 million for the quarter ended December 31, 2025. For the year ended December 31, 2025, the Company...
03-30 16:33
Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.50) per share. This is a 99.14 percent increase over losses of $(57.96) per share from the same period last year.
03-28 05:52
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-treatment-for-veterans/
03-28 01:28
BRIEF-Enveric Biosciences Announces Registration Of Five Trademarks March 18 (Reuters) - Enveric Biosciences Inc ENVB.O : ENVERIC BIOSCIENCES ANNOUNCES REGISTRATION OF FIVE TRADEMARKS Source text: ID:nBw5k8BqTa Further company coverage: ENVB.O (( Reuters.Briefs@thomsonreuters.com ;))
03-18 20:02
Enveric Biosciences shares are trading higher after the company announced new m...
02-19 21:05
An announcement from Enveric Biosciences ( ($ENVB) ) is now available. On Febru...
02-07 06:21
Enveric Biosciences shares are trading lower after the company announced a $1.5...
01-28 21:06
Enveric Biosciences ( ($ENVB) ) just unveiled an update. On or about January 9,...
01-10 06:49